BE899790A - 3-(3-hydroxybutoxy)-1-butanol et sa preparation. - Google Patents

3-(3-hydroxybutoxy)-1-butanol et sa preparation.

Info

Publication number
BE899790A
BE899790A BE0/213036A BE213036A BE899790A BE 899790 A BE899790 A BE 899790A BE 0/213036 A BE0/213036 A BE 0/213036A BE 213036 A BE213036 A BE 213036A BE 899790 A BE899790 A BE 899790A
Authority
BE
Belgium
Prior art keywords
butanol
preparation
hydroxybutoxy
isomers
pure
Prior art date
Application number
BE0/213036A
Other languages
English (en)
French (fr)
Inventor
E Manghisi
A Salimbeni
Original Assignee
Luso Farmaco Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Luso Farmaco Inst filed Critical Luso Farmaco Inst
Publication of BE899790A publication Critical patent/BE899790A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/04—Saturated ethers
    • C07C43/13—Saturated ethers containing hydroxy or O-metal groups
    • C07C43/132—Saturated ethers containing hydroxy or O-metal groups both carbon chains being substituted by hydroxy or O-metal groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14—Unsaturated ethers
    • C07C43/164—Unsaturated ethers containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14—Unsaturated ethers
    • C07C43/178—Unsaturated ethers containing hydroxy or O-metal groups
    • C07C43/1785—Unsaturated ethers containing hydroxy or O-metal groups having more than one ether bound

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE0/213036A 1983-05-30 1984-05-30 3-(3-hydroxybutoxy)-1-butanol et sa preparation. BE899790A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT21352/83A IT1164254B (it) 1983-05-30 1983-05-30 3-(3-idrossibutossi)-1-butanolo e suo metodo di preparazione

Publications (1)

Publication Number Publication Date
BE899790A true BE899790A (fr) 1984-11-30

Family

ID=11180528

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/213036A BE899790A (fr) 1983-05-30 1984-05-30 3-(3-hydroxybutoxy)-1-butanol et sa preparation.

Country Status (8)

Country Link
US (1) US4584321A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS604146A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE (1) BE899790A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3419947A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES8507449A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2547813B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB2142623B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IT (1) IT1164254B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1204626B1 (en) * 1999-04-01 2008-01-16 Esperion Therapeutics Inc. Ether compounds, compositions, and uses thereof
CN1962596A (zh) 2000-10-11 2007-05-16 埃斯佩里安医疗公司 用于控制胆固醇以及相关用途的酮化合物以及组合物
US7304093B2 (en) * 2000-10-11 2007-12-04 Esperion Therapeutics, Inc. Ketone compounds and compositions for cholesterol management and related uses
US20040122091A1 (en) * 2000-10-11 2004-06-24 Esperion Therapeutics, Inc. Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
MXPA03003022A (es) 2000-10-11 2003-07-14 Esperion Therapeutics Inc Compuestos de sulfuro y disulfuro y composiciones para el control del colesterol y usos relacionados.
IL155215A0 (en) 2000-10-11 2003-11-23 Esperion Therapeutics Inc Ether compounds and compositions for cholesterol management and related uses
WO2002030882A2 (en) 2000-10-11 2002-04-18 Esperion Therapeutics, Inc. Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
US20040204502A1 (en) * 2001-10-11 2004-10-14 Dasseux Jean-Louis Henri Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
US20040192771A1 (en) * 2001-10-11 2004-09-30 Dasseux Jean-Louis Henri Ether compounds and compositions for cholesterol management and related uses
US20050020694A1 (en) * 2001-10-11 2005-01-27 Dasseux Jean-Louis Henri Sulfide and disulfide compounds and compositions for cholesterol management and related uses
US20030236213A1 (en) * 2002-04-10 2003-12-25 Jean-Louis Dasseux Mimics of acyl coenzyme-A comprising pantolactone and pantothenic acid derivatives, compositions thereof, and methods of cholesterol management and related uses
MX349134B (es) 2003-01-23 2017-07-12 Esperion Therapeutics Inc Compuestos de hidroxilo y composiciones para el manejo del colesterol y usos relacionados.
JP2007525408A (ja) * 2003-12-24 2007-09-06 エスペリオン セラピューティクス，インコーポレイテッド コレステロール管理および関連使用のためのケトン化合物および組成物
CN103848726B (zh) * 2012-12-09 2017-09-05 河北凯盛医药科技有限公司 一种高纯度二羟二丁基醚及其制备方法
CN103304383B (zh) * 2013-06-18 2015-04-08 重庆医科大学 保胆健素的新合成方法
CN103333057A (zh) * 2013-06-24 2013-10-02 大连理工大学 一种二羟基二丁醚的制备方法
CN103319316B (zh) * 2013-06-24 2015-06-10 大连理工大学 一种二羟基二丁醚的绿色制备方法
CN104230674A (zh) * 2014-08-28 2014-12-24 成都邦泽生物医药科技有限公司 一种二羟基二丁醚的制备方法
BR112017019358A2 (pt) 2015-03-13 2018-05-08 Esperion Therapeutics Inc combinações e formulações de dose fixa compreendendo etc1002 e ezetimiba e métodos de tratamento ou redução do risco de doença cardiovascular
MA41793A (fr) 2015-03-16 2018-01-23 Esperion Therapeutics Inc Associations de doses fixes comprenant du etc1002 et une ou plusieurs statines permettant de traiter ou de réduire un risque cardiovasculaire
AU2020296094B2 (en) 2019-06-21 2025-02-06 Esperion Therapeutics, Inc. Methods of making bempedoic acid and compositions of the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT957008B (it) * 1967-11-09 1973-10-10 Luso Farmaco Inst Processo per la preparazione di eteri simmetrici di glicoli re canti ossidrili primari e secon dari
DE2218935C3 (de) * 1972-04-19 1980-01-31 Basf Ag, 6700 Ludwigshafen Verfahren zur Herstellung von wäßrigen Lösungen von N-Vinylpyrrolidonpolymerisaten

Also Published As

Publication number Publication date
IT8321352A1 (it) 1984-11-30
FR2547813B1 (fr) 1989-01-27
DE3419947C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1987-11-26
GB8411356D0 (en) 1984-06-06
FR2547813A1 (fr) 1984-12-28
GB2142623B (en) 1987-04-15
US4584321A (en) 1986-04-22
JPS6241702B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1987-09-04
ES532802A0 (es) 1985-10-01
DE3419947A1 (de) 1984-12-06
IT8321352A0 (it) 1983-05-30
GB2142623A (en) 1985-01-23
IT1164254B (it) 1987-04-08
JPS604146A (ja) 1985-01-10
ES8507449A1 (es) 1985-10-01

Similar Documents

Publication Publication Date Title
BE899790A (fr) 3-(3-hydroxybutoxy)-1-butanol et sa preparation.
FR2430410A1 (fr) Phenethanolamines et compositions pharmaceutiques en contenant
ES2194987T3 (es) Compuestos triciclicos utiles para inhibir la farnesil-protein-transferasa.
ES2117646T3 (es) Alteracion de la velocidad y el caracter del crecimiento del pelo.
NO900251L (no) Fremgangsmaate for behandling eller hindring av intrinsik aldret hud med retinoider.
ATE15596T1 (de) Pharmazeutische mittel.
BE900855A (fr) Compositions pour le traitement prophylactique de l'osteite et de l'osteomyelite.
TNSN87012A1 (fr) Nouveaux derives de dihydrobenzofuranne - et de chromane - carboxamides, leurs procedes de preparation et leur utilisation comme neuroleptiques
EP0183572A3 (en) A gangliosides mixture, useful as a therapeutical tool for eliminating painful effects of peripheral neuropathies
DE69506686D1 (de) Verwendung von bis (amidinobenzidazolen) zur herstellung eines medikamentes für die hemmung der retroviral integrase
BE901210A (fr) Nouveaux retinoides.
FR2430408A1 (fr) Phenethanolamines optiquement actives et leur utilisation therapeutique
FR2434802A1 (fr) Oxime-carbamates et carbonates utiles pour la protection des cultures
BE901266A (fr) Nouveaux derives de 3-benzylidene camphre, leur procede de preparation et leur utilisation en tant qu'agents de protection contre les rayons uv et produits ainsi obtenus.
FR2455587A1 (fr) Derives de benzimidazole, leur preparation et utilisation dans le traitement des affections cardiovasculaires et compositions les contenant
FR2407203A1 (fr) Azetidinones monocycliques antibiotiques
FR2738150B1 (fr) Utilisation de la sulphasalazine et de ses metabolites pour la fabrication d'un medicament utile dans le traitement de l'insuffisance veineuse et des ulceres veineux
EP0674521A4 (en) METHOD FOR TREATING CHRONIC PROSTATITIS WITH 17-BETA-N MONO SUBSTITUTED CARBAMOYL-4-AZA-5 ALPHA-ANDROST-1-EN-3-ONES.
ES2002207A6 (es) Un metodo para producir derivados de glucosilmoranolina
FI870460A0 (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 5-substituerade oktahydroindolizinderivat och vid foerfarandet anvaendbara mellanprodukter.
BE1002121A4 (fr) Derives de la 2,3,4,5,6,7-hexahydro-2,7-methano-1,5-benzoxazonine (ou -1,4-benzoxazonine), procede pour leur preparation et medicaments les contenant.
FR2420595A1 (fr) Utilisation d'ethers tert-butyliques comme agents d'appretage de fibres
FR2358884A1 (fr) Compositions d'amino-alcools et leur procede de preparation et leur application notamment pour le traitement d'affections buccales
FR2698789B1 (fr) Utilisation de l'idazoxan et ses dérivés pour la préparation d'un médicament destiné au traitement de la maladie de Parkinson et de son évolution.
TNSN86165A1 (fr) Nouveaux ortho-anisamides, leur procede d'obtention et leurs applications therapeutiques

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: *ISTITUTO LUSO FARMACO D ITALIA S.P.A.

Effective date: 20040530